Clinical Trial Update: Prophylactic Anecortave Acetate in Patients With a Retisert Implant [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating prophylactic anecortave acetate in patients with a Retisert implant has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Posterior Uveitis

Drugs mentioned

• anecortave acetate (anecortave acetate)

Snippet

Sponsor: Texas Retina Associates | Conditions: Uveitis, Posterior, Glaucoma | Phase 1 | Status: COMPLETED